Results demonstrate various quantitative levels of the EGFR peptide in patient tumor tissue samples with a broad range from ND to 660.73amol/μg (10X LOQ) with variation ranging from CV = 0.77 % to 35.38 % (Figure 3). This evidence concerns the gene EGFR and neoplasm.